Kevin G Blyth

21PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Implementation science and evaluationMolecular targetsArtificial life and complex adaptive systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 07, 2026
Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer in a real-world Dutch cohort receiving chemotherapy and/or immunotherapy.

|Jul 01, 2026
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).

|May 08, 2026
Impact of a national mesothelioma network on outcomes including survival.

|Dec 10, 2025
First-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trial.

Krishan Ragab Bansal, David T Arnold, Emma Tucker

|Nov 01, 2025
Intratumour, anatomical and temporal heterogeneity in mesothelioma.

Maya Arnould, Mark D J Neilly, Kevin G Blyth

|Jun 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.

Matthew Tate, Christopher J R Illingworth, Gordon MacGregor

Pageof 4

Frequent Collaborators

3 joint publications

Matthew Evison

3 joint publications

Andrew Stanton

2 joint publications

Geraldine Lynch

2 joint publications

Maged Hassan